← Leaderboards
Dexing Fang
Oncoimmune, Inc.
$643,763
Attributed
$643,763
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $493.6K · FY2010–11$500K$375K$250K$125K$0
'10
'11
Funding mix
By agency
NIH$643,763 · 2
By mechanism
R44$493,610 · 1
R43$150,153 · 1
Top collaborators
No co-investigators on record.
Most similar at Oncoimmune, Inc.
Same institution · by research overlap
- Martin Devenport$1,988,729
- Yunbiao Lu$155,180
- Siwen Hu-Lieskovan$198,332
Others in their field
Top investigators on “Extracellular Domain”
- Timothy A Springer · Boston Children'S Hospital$20,641,895
- Raymond C Stevens · University Of Calif-Lawrenc Berkeley Lab$17,075,965
- Jun Qin · Cleveland Clinic Foundation$16,872,231
- Dana Dabelea · University Of Colorado Denver$14,881,123
- Mark A. Lemmon · Yale University$13,422,846
- Donald W. Kufe · Dana-Farber Cancer Inst$13,039,098
Research focus
Extracellular DomainChronicIn VivoPathogenesisChimeric ProteinsAutoimmune DiseasesDrug Delivery SystemsIgg1Therapeutic EffectPharmaceutical PreparationsBaseCell LineCd28 GeneCellsB-LymphocytesArthritisAffectBiologicalCollagen ArthritisCollagenComplementCtla4 GeneCyclic GmpBinding (Molecular Function)